维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

6篇 您的检索式：作者名="Barrette V F"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Effect of Regu- lar Exercise on the Radiographic Progression of Foot Osteoarthritis显示文摘	Wilder F V Barrett J P Farina E J	2005	Am Podiatry Med Assoc2005，95，4：	1
	2	Hemody- namic and behavioral differences after administration of meloxi- cam, buprenorphine, or tramadol as analgesics for telemeter implantation in mice 显示文摘	Ratsep M T Barrette V F Winterborn A	2013	Journal of the American Association for Laboratory Animal Science2013，52，5：	1
	3	Iquitos virus:a novel reassortant Orthobunyavirus associated with human ill-ness in Peru显示文摘	Aguilar P V Barrett A D Saeed M F	2011	PLoS Negl Trop Dis2011，5，9：	1
	4	Validity of Personnel Decisions:A Conceptual Analysis of the Inferential and Evidential Bases显示文摘	Binning J F Barrett G V	1989	Journal of Applied Psychology1989，74，3：	1
	5	Spiral arterial remodeling is not essential for normal blood pressure regulation in pregnant mice 显示文摘	Burke S D Barrette V F Bianco J	2010	Hypertension2010，55，3：	1
	6	Sugammadex: Role in current anaesthetic practice and its safety benefits for patients显示文摘Sugammadex has revolutionized anaesthetic management of reversal of neuromuscular block(NMB) by way of its unique mechanism of action encapsulating the amino steroid neuromuscular blocking drugs rocuroniumand vecuronium. The cholinesterase inhibitors have significant pharmacological and clinical limitations whereas sugammadex allows predictable, safe and rapid reversal from any depth of blockade. The financial cost of sugammadex is significant. Many hospitals in the United Kingdom use clinical guidelines to direct best use of sugammadex in their institutions. Auditing the use of sugammadex provides useful information on which patients are benefiting from sugammadex. The clinical benefits of sugammadex are well understood. No patient should now be subjected to the danger of post-operative residual curarization. Versatility in the ability to reverse NMB has brought opportunities to the anaesthetist in the management of rapid sequence induction using high dose rocuronium with the knowledge that safe reversal of NMB is now possible in the unlikely event of a 'can't intubate can't ventilate' situation. Do we still need suxamethonium to be available? The nature of surgery continues to evolve with ever-increasing enthusiasm for minimally invasive laparoscopic techniques. There is evidence to support using a deeper level of NMB to improve the working space and operating conditions in laparoscopic surgery. It is now possible to maintain a deep level of NMB right up until the end of surgery with no concerns about the ability to effect safe reversal of NMB. Vigilance about the possibility of allergic sensitivity to sugammadex needs to be maintained. The increased usage of rocuronium has the potential for rocuroniuminduced anaphylaxis. Conversely, there is a potential role for sugammadex in the treatment of rocuronium anaphylaxis. Clinicians who have used sugammadex are struck with the quality of recovery seen in their patients. It is important that the economic implications of the use of sugammadex are fully understood. This article considers the current role of sugammadex in clinical practice outside of routine reversal of NMB and discusses how the addition of sugammadex to the anaesthetic armamentarium brings safety benefits for patients.	Michael V Copp Thomas F Barrett	2015	World Journal of Anesthesiology2015，4，3：	0

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费